Skip to main content
Top
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology 8/2016

01-08-2016 | Retinal Disorders

Optical coherence tomography angiography in patients with polypoidal choroidal vasculopathy

Authors: Ju Young Kim, Oh Woong Kwon, Hyun Sub Oh, Soon Hyun Kim, Yong Sung You

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 8/2016

Login to get access

Abstract

Purpose

To report the characteristics of polypoidal choroidal vasculopathy (PCV) based on optical coherence tomography angiography (OCTA) results.

Method

A retrospective, cross-sectional case series was conducted. Patients treated for PCV were evaluated with the OCTA system. The OCTA images of these patients were compared with those from indocyanine green angiography (ICGA). All eyes of consecutive patients with PCV were included.

Results

The mean age of the patients (five men and two women) was 67.86 ± 14.02 years. The mean number of anti-vascular endothelial growth factor injections was 10.43 ± 10.01. OCTA demonstrated branched vascular networks, which were detected by ICGA; however, polyps were not revealed consistently by OCTA. A total of 24 polyps were detected in seven eyes from seven patients by hyper-fluorescence on ICGA. However, only 12 polyps (50 %) were hyper-reflective on OCTA.

Conclusion

PCV polyps were not detected as consistently by OCTA as by ICGA. This suggests that the polyps were detected differently by OCTA depending on blood flow in the polyp.
Literature
1.
go back to reference Li X (2013) Polypoidal choroidal vasculopathy. In: Ryan SJ, Sadda SR, Hinton DR (eds) Retina, 5th edn. Elsevier, China, pp 1285–1290CrossRef Li X (2013) Polypoidal choroidal vasculopathy. In: Ryan SJ, Sadda SR, Hinton DR (eds) Retina, 5th edn. Elsevier, China, pp 1285–1290CrossRef
2.
go back to reference Yannuzzi LA, Wong DW, Sforzolini BS, Goldbaum M, Tang KC, Spaide RF, Freund KB, Slakter JS, Guyer DR, Sorenson JA, Fisher Y, Maberley D, Orlock DA (1999) Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration. Arch Ophthalmol 117:1503–1510CrossRefPubMed Yannuzzi LA, Wong DW, Sforzolini BS, Goldbaum M, Tang KC, Spaide RF, Freund KB, Slakter JS, Guyer DR, Sorenson JA, Fisher Y, Maberley D, Orlock DA (1999) Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration. Arch Ophthalmol 117:1503–1510CrossRefPubMed
3.
go back to reference Wen F, Chen C, Wu D, Li H (2004) Polypoidal choroidal vasculopathy in elderly Chinese patients. Graefes Arch Clin Exp Ophthalmol 242:625–629CrossRefPubMed Wen F, Chen C, Wu D, Li H (2004) Polypoidal choroidal vasculopathy in elderly Chinese patients. Graefes Arch Clin Exp Ophthalmol 242:625–629CrossRefPubMed
4.
go back to reference Maruko I, Iida T, Saito M, Nagayama D, Saito K (2007) Clinical characteristics of exudative age-related macular degeneration in Japanese patients. Am J Ophthalmol 144:15–22CrossRefPubMed Maruko I, Iida T, Saito M, Nagayama D, Saito K (2007) Clinical characteristics of exudative age-related macular degeneration in Japanese patients. Am J Ophthalmol 144:15–22CrossRefPubMed
5.
go back to reference Uyama M, Wada M, Nagai Y, Matsubara T, Matsunaga H, Fukushima I, Takahashi K, Matsumura M (2002) Polypoidal choroidal vasculopathy: natural history. Am J Ophthalmol 133:639–648CrossRefPubMed Uyama M, Wada M, Nagai Y, Matsubara T, Matsunaga H, Fukushima I, Takahashi K, Matsumura M (2002) Polypoidal choroidal vasculopathy: natural history. Am J Ophthalmol 133:639–648CrossRefPubMed
6.
go back to reference Koh AH, Chen LJ, Chen SJ, Chen Y, Giridhar A, Iida T, Kim H, Yuk Yau Lai T, Lee WK, Li X, Han Lim T, Ruamviboonsuk P, Sharma T, Tang S, Yuzawa M (2013) Polypoidal choroidal vasculopathy: evidence-based guidelines for clinical diagnosis and treatment. Retina 33:686–716CrossRefPubMed Koh AH, Chen LJ, Chen SJ, Chen Y, Giridhar A, Iida T, Kim H, Yuk Yau Lai T, Lee WK, Li X, Han Lim T, Ruamviboonsuk P, Sharma T, Tang S, Yuzawa M (2013) Polypoidal choroidal vasculopathy: evidence-based guidelines for clinical diagnosis and treatment. Retina 33:686–716CrossRefPubMed
7.
go back to reference Ojima Y, Hangai M, Sakamoto A, Tsujikawa A, Otani A, Tamura H, Yoshimura N (2009) Improved visualization of polypoidal choroidal vasculopathy lesions using spectral-domain optical coherence tomography. Retina 29:52–59CrossRefPubMed Ojima Y, Hangai M, Sakamoto A, Tsujikawa A, Otani A, Tamura H, Yoshimura N (2009) Improved visualization of polypoidal choroidal vasculopathy lesions using spectral-domain optical coherence tomography. Retina 29:52–59CrossRefPubMed
8.
go back to reference Moult E, Choi W, Waheed NK, Adhi M, Lee B, Lu CD, Jayaraman V, Potsaid B, Rosenfeld PJ, Duker JS, Fujimoto JG (2014) Ultrahigh-speed swept-source OCT angiography in exudative AMD. Ophthalmic Surg Lasers Imaging Retina 45:496–505CrossRefPubMedPubMedCentral Moult E, Choi W, Waheed NK, Adhi M, Lee B, Lu CD, Jayaraman V, Potsaid B, Rosenfeld PJ, Duker JS, Fujimoto JG (2014) Ultrahigh-speed swept-source OCT angiography in exudative AMD. Ophthalmic Surg Lasers Imaging Retina 45:496–505CrossRefPubMedPubMedCentral
9.
go back to reference de Carlo TE, Bonini Filho MA, Chin AT, Adhi M, Ferrara D, Baumal CR, Witkin AJ, Reichel E, Duker JS, Waheed NK (2015) Spectral-domain optical coherence tomography angiography of choroidal neovascularization. Ophthalmology 122:1228–1238CrossRefPubMed de Carlo TE, Bonini Filho MA, Chin AT, Adhi M, Ferrara D, Baumal CR, Witkin AJ, Reichel E, Duker JS, Waheed NK (2015) Spectral-domain optical coherence tomography angiography of choroidal neovascularization. Ophthalmology 122:1228–1238CrossRefPubMed
10.
go back to reference Miura M, Muramatsu D, Hong YJ, Yasuno Y, Iwasaki T, Goto H (2015) Noninvasive vascular imaging of polypoidal choroidal vasculopathy by doppler optical coherence tomography. Invest Ophthalmol Vis Sci 56:3179–3186CrossRefPubMed Miura M, Muramatsu D, Hong YJ, Yasuno Y, Iwasaki T, Goto H (2015) Noninvasive vascular imaging of polypoidal choroidal vasculopathy by doppler optical coherence tomography. Invest Ophthalmol Vis Sci 56:3179–3186CrossRefPubMed
11.
go back to reference Hope-Ross M, Yannuzzi LA, Gragoudas ES, Guyer DR, Slakter JS, Sorenson JA, Krupsky S, Orlock DA, Puliafito CA (1994) Adverse reactions due to indocyanine green. Ophthalmology 101:529–533CrossRefPubMed Hope-Ross M, Yannuzzi LA, Gragoudas ES, Guyer DR, Slakter JS, Sorenson JA, Krupsky S, Orlock DA, Puliafito CA (1994) Adverse reactions due to indocyanine green. Ophthalmology 101:529–533CrossRefPubMed
12.
go back to reference Kuehlewein L, Sadda SR, Sarraf D (2015) OCT angiography and sequential quantitative analysis of type 2 neovascularization after ranibizumab therapy. Eye (Lond). doi:10.1038/eye.2015.80 Kuehlewein L, Sadda SR, Sarraf D (2015) OCT angiography and sequential quantitative analysis of type 2 neovascularization after ranibizumab therapy. Eye (Lond). doi:10.​1038/​eye.​2015.​80
13.
go back to reference Nagiel A, Sadda SR, Sarraf D (2015) A promising future for optical coherence tomography angiography. JAMA Ophthalmol 133:629–630CrossRefPubMed Nagiel A, Sadda SR, Sarraf D (2015) A promising future for optical coherence tomography angiography. JAMA Ophthalmol 133:629–630CrossRefPubMed
14.
go back to reference Spaide RF (2015) Optical coherence tomography angiography signs of vascular abnormalization with antiangiogenic therapy for choroidal neovascularization. Am J Ophthalmol 160:6–16CrossRefPubMed Spaide RF (2015) Optical coherence tomography angiography signs of vascular abnormalization with antiangiogenic therapy for choroidal neovascularization. Am J Ophthalmol 160:6–16CrossRefPubMed
15.
go back to reference Dansingani KK, Naysan J, Freund KB (2015) En face OCT angiography demonstrates flow in early type 3 neovascularization (retinal angiomatous proliferation). Eye (Lond) 29:703–706CrossRef Dansingani KK, Naysan J, Freund KB (2015) En face OCT angiography demonstrates flow in early type 3 neovascularization (retinal angiomatous proliferation). Eye (Lond) 29:703–706CrossRef
16.
go back to reference Maftouhi MQ-E, Maftouhi AE (2015) OCT angiography examination of choroidal neovascular membrane in other disorders. In: Lumbroso B, Huang D, Jia Y, Romano A, Chen CJ, Rispoli M, Waheed NK (eds) Clinical OCT angiography atlas, 1st edn. Jayppe Brothers Medical Publishers (P) Ltd, India, pp 62–63 Maftouhi MQ-E, Maftouhi AE (2015) OCT angiography examination of choroidal neovascular membrane in other disorders. In: Lumbroso B, Huang D, Jia Y, Romano A, Chen CJ, Rispoli M, Waheed NK (eds) Clinical OCT angiography atlas, 1st edn. Jayppe Brothers Medical Publishers (P) Ltd, India, pp 62–63
17.
go back to reference Kawamura A, Yuzawa M, Mori R, Haruyama M, Tanaka K (2013) Indocyanine green angiographic and optical coherence tomographic findings support classification of polypoidal choroidal vasculopathy into two types. Acta Ophthalmol 91:e474–e481CrossRefPubMed Kawamura A, Yuzawa M, Mori R, Haruyama M, Tanaka K (2013) Indocyanine green angiographic and optical coherence tomographic findings support classification of polypoidal choroidal vasculopathy into two types. Acta Ophthalmol 91:e474–e481CrossRefPubMed
Metadata
Title
Optical coherence tomography angiography in patients with polypoidal choroidal vasculopathy
Authors
Ju Young Kim
Oh Woong Kwon
Hyun Sub Oh
Soon Hyun Kim
Yong Sung You
Publication date
01-08-2016
Publisher
Springer Berlin Heidelberg
Published in
Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 8/2016
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-015-3228-3

Other articles of this Issue 8/2016

Graefe's Archive for Clinical and Experimental Ophthalmology 8/2016 Go to the issue